Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,714 | 7,753 | 8,066 | 10,250 | 16,904 |
| Other current assets | 0 | 624 | 715 | 691 | 689 |
| TOTAL | $10,659 | $10,012 | $9,579 | $12,074 | $19,066 |
| Non-Current Assets | |||||
| PPE Net | 543 | 614 | 697 | 789 | 895 |
| Other Non-Current Assets | 4,389 | 4,520 | 4,645 | 4,766 | 4,881 |
| TOTAL | $4,932 | $5,134 | $5,342 | $5,555 | $5,776 |
| Total Assets | $15,591 | $15,146 | $14,921 | $17,629 | $24,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,242 | 3,532 | 3,736 | 3,720 | 3,984 |
| Accrued Expenses | 4,197 | 922 | 892 | 1,610 | 2,098 |
| Other current liabilities | N/A | 1,428 | 791 | 968 | 1,142 |
| TOTAL | $6,207 | $5,882 | $5,419 | $6,298 | $7,224 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,629 | 4,844 | 5,039 | 5,228 | 5,397 |
| TOTAL | $4,629 | $4,844 | $5,039 | $5,228 | $5,397 |
| Total Liabilities | $10,836 | $10,726 | $10,458 | $11,526 | $12,621 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4 | 1 | 1 | 0 | 23,472 |
| Common Shares | 84 | 82 | 69 | 66 | 61 |
| Retained earnings | -247,577 | -241,265 | -236,164 | -230,281 | -223,447 |
| TOTAL | $4,755 | $4,420 | $4,463 | $6,103 | $12,221 |
| Total Liabilities And Equity | $15,591 | $15,146 | $14,921 | $17,629 | $24,842 |